MiNK Therapeutics Inc (INKT) Stock Price, Quote, News & History

INKTNASDAQ
$11.64
0.413.65%
At close: Sep 4, 5:00 PM EST
$11.41
-0.23-1.98%
After Hours: Sep 4, 4:04 PM EST

MiNK Therapeutics (INKT) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-6.83M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
13.99M
Free Cash Flow (TTM)
-6.83M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
7.16M

Analyst Trends and Forecast

1
Apr
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$51.22M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-20.94%
Earnings Yield % (FWD)
-17.40%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$2.75

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$8.81M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$11.16
Close
$11.64
Volume / Avg.
5.87K / 15.82K
Day Range
$11.16 - $11.64
52 Wk Range
8.48 - 16.98
Market Cap
$58.23M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
51
Short Interest
3.07%
Days to Cover
9.04

About

Sector
Health Care
Industry
Biotechnology
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated disea...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy MiNK Therapeutics (INKT) stock?

A

You can purchase shares of MiNK Therapeutics (NASDAQ:INKT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are MiNK Therapeutics (INKT) competitors?

Q

What is the forecast, or price target, for MiNK Therapeutics (INKT) stock?

A

MiNK Therapeutics has a consensus price target of $19.50.

Q

What is the current price for MiNK Therapeutics (INKT)?

A

The stock price for MiNK Therapeutics (NASDAQ: INKT) is $11.41 last updated September 4, 2026 at 4:04 PM EDT.

Q

Does MiNK Therapeutics (INKT) pay a dividend?

A

There are no upcoming dividends for MiNK Therapeutics.

Q

When is MiNK Therapeutics (NASDAQ:INKT) reporting earnings?

A

MiNK Therapeutics does not have any upcoming earnings scheduled.

Q

Is MiNK Therapeutics (INKT) going to split?

A

There is no upcoming split for MiNK Therapeutics.

Q

What sector and industry does MiNK Therapeutics (INKT) operate in?

A

MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.